New York was the only state to receive the highest mark on the ALS Association’s latest report cards, the association said.

A 22-month survival benefit was seen for a subset of ALS patients whose disease did not progress when treated with NP001 in ...

Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

ALS took many things from columnist Juliet Taylor's late husband, Jeff, including the end of his career, which was ...

Riluzole treatment and a diet containing high glycemic index foods interact 'synergistically' to slow ALS progression, ...

A study in Italy found ALS incidence and onset rose with living near arable crops (cereals, beans, root crops), and with ...

The ALS Association will host its second ALS Nexus conference in August, with the goal of making the disease a livable one ...

Half of ALS patients experience constipation, which is associated with faster progression and lower survival rates, per a ...

Columnist Kristin Neva had been searching awhile for equipment that would help with her husband's ALS management. It took repeated searches.

The U.S. Food and Drug Administration (FDA) has lifted the clinical hold on a Phase 1 clinical trial that’s testing AMX0114, Amylyx Pharmaceuticals’ investigational treatment for amyotrophic lateral ...